artemotil has been researched along with Disease Models, Animal in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Ashfaq, MK; Jacob, MR; Joshi, VC; Khan, SI; Manly, SP; Muhammad, I; Samoylenko, V; Tekwani, BL; Walker, LA | 1 |
| Dawre, S; Devarajan, PV; Pathak, S; Sharma, S | 1 |
| Kumar, KK; Prasad, DM; Rajyalakshmi, M; Satish, PV; Sowjanya, M; Sunita, K | 1 |
| Dende, C; Meena, J; Nagarajan, P; Padmanaban, G; Panda, AK; Rangarajan, PN | 1 |
| Dhawan, S; Gunjan, S; Pal, A; Tripathi, R | 1 |
| Chauhan, BS; Dwivedi, H; Gunjan, S; Singh, SK; Tripathi, R | 1 |
| Gugulothu, D; Pathak, S; Patravale, V; Sharma, S; Suryavanshi, S | 1 |
| Aditya, NP; Banerjee, R; Chimote, G; Gunalan, K; Madhusudhan, B; Patankar, S | 1 |
| Memvanga, PB; Préat, V | 1 |
| Agrawal, A | 1 |
| Ager, AL; Canfield, CJ; Heiffer, MH; Klayman, DL; Kyle, DE; Milhous, WK; Rossan, RN; Schuster, BG; Shmuklarsky, MJ; Tang, DB | 1 |
| Dutta, GP; Tripathi, R; Vishwakarma, RA | 2 |
| Bauman, RA; Brewer, TG; Corcoran, KD; Gettayacamin, M; Kyle, DE; Peggins, JO; Petras, JM; Vane, MA; Webster, HK; Young, GD | 1 |
15 other study(ies) available for artemotil and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Indolizidine, antiinfective and antiparasitic compounds from Prosopis glandulosa var. glandulosa.
Topics: Animals; Anti-Infective Agents; Antiparasitic Agents; Aspergillus fumigatus; Brain; Candida albicans; Chloroquine; Cryptococcus neoformans; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Indolizidines; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Nevada; Plants, Medicinal; Plasmodium berghei; Prosopis | 2009 |
Enhanced antimalalarial activity of a prolonged release in situ gel of arteether-lumefantrine in a murine model.
Topics: Animals; Antimalarials; Artemisinins; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Drug Therapy, Combination; Ethanolamines; Fluorenes; Gels; Lumefantrine; Malaria, Falciparum; Male; Mice; Polymers | 2018 |
Human malaria in C57BL/6J mice: an in vivo model for chemotherapy studies.
Topics: Animals; Artemisinins; Artesunate; Disease Models, Animal; Drug Resistance, Multiple; Female; Humans; Malaria; Mice; Mice, Inbred C57BL; Parasitemia; Plasmodium falciparum | 2014 |
Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria.
Topics: Animals; Artemisinins; Brain; Curcumin; Disease Models, Animal; Drug Therapy, Combination; Encephalitis; Erythrocytes; Malaria, Cerebral; Mice; Plasmodium berghei | 2015 |
Potentiation of antimalarial activity of arteether in combination with Vetiver root extract.
Topics: Animals; Antimalarials; Artemisinins; Chrysopogon; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Malaria; Mice; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Plasmodium yoelii; Remission Induction; Time Factors | 2016 |
Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration.
Topics: Animals; Antimalarials; Artemisinins; Brain; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Gene Expression Profiling; Injections, Intramuscular; Malaria, Cerebral; Mice; Survival Analysis; Treatment Outcome; Vitamin D | 2016 |
Self-microemulsifiyng suppository formulation of β-artemether.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Compounding; Emulsions; Humans; Malaria; Male; Mice; Mice, Inbred Strains; Suppositories | 2010 |
Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice.
Topics: Animals; Antimalarials; Artemisinins; Curcuma; Curcumin; Diarylheptanoids; Disease Models, Animal; Hemolysis; Humans; Liposomes; Malaria; Mice; Phytotherapy; Plant Extracts; Plant Roots; Plasmodium berghei; Polyphenols | 2012 |
Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Caco-2 Cells; Disease Models, Animal; Drug Delivery Systems; Drug Design; Emulsions; Excipients; Humans; Lipids; Malaria; Mice; Plasmodium berghei; Solubility | 2012 |
Studies on drug metabolizing enzymes during arteether treatment of Plasmodium yoelii nigeriensis infected mice cerebral microvessels.
Topics: Animals; Antimalarials; Artemisinins; Brain; Disease Models, Animal; Malaria, Cerebral; Mice; Muscle, Smooth, Vascular; Plasmodium yoelii | 2005 |
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Malaria; Malaria, Falciparum; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1993 |
Gametocytocidal activity of alpha/beta arteether by the oral route of administration.
Topics: Administration, Oral; Animals; Anopheles; Antimalarials; Artemisinins; Disease Models, Animal; Macaca mulatta; Malaria; Plasmodium cynomolgi; Sesquiterpenes | 1996 |
Arteether: risks of two-week administration in Macaca mulatta.
Topics: Animals; Antimalarials; Artemisinins; Central Nervous System; Cranial Nerves; Disease Models, Animal; Macaca mulatta; Male; Neurons; Olivary Nucleus; Reticular Formation; Sesquiterpenes; Vestibular Nuclei | 1997 |
Plasmodium fragile: efficacy of arteether (alpha/beta) against cerebral malaria model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Female; Macaca mulatta; Malaria, Cerebral; Male; Parasitemia; Plasmodium; Sesquiterpenes | 1997 |